设万维读者为首页 万维读者网 -- 全球华人的精神家园 广告服务 联系我们 关于万维
 
首  页 新  闻 视  频 博  客 论  坛 分类广告 购  物
搜索>> 发表日志 控制面板 个人相册 给我留言
帮助 退出
 
Pascal的博客  
日光之下并无新事;一切历史都是当代史。  
我的名片
Pascal
注册日期: 2014-10-22
访问总量: 12,589,182 次
点击查看我的个人资料
Calendar
我的公告栏
最新发布
· 万维哈马斯今日狂喜.我的最爱-25
· 昨日英美雄文震撼世界.帮疫苗厂
· 满世界就剩下了你还在为苗害洗地
· 举报北大陈宝权同志2020年向2025
· 有人说.千万不要接种美国FDA批准
· 六年了还在发酵.美国参议员最早
· 再看如果中国民主了的27大改变.
友好链接
分类目录
【他山之石】
· 万维哈马斯今日狂喜.我的最爱-25
· 昨日英美雄文震撼世界.帮疫苗厂
· 满世界就剩下了你还在为苗害洗地
· 举报北大陈宝权同志2020年向2025
· 有人说.千万不要接种美国FDA批准
· 六年了还在发酵.美国参议员最早
· 再看如果中国民主了的27大改变.
· 华夏史上3000年一见天子明君思想
· 秋后算账.资深护士曝死于新冠病
· 再看千年一见英雄卢沙野大使怒斥
存档目录
11/01/2026 - 11/30/2026
10/01/2026 - 10/31/2026
09/01/2026 - 09/30/2026
08/01/2026 - 08/31/2026
07/01/2026 - 07/31/2026
06/01/2026 - 06/30/2026
05/01/2026 - 05/31/2026
04/01/2026 - 04/30/2026
03/01/2026 - 03/31/2026
02/01/2026 - 02/28/2026
01/01/2026 - 01/31/2026
12/01/2025 - 12/31/2025
11/01/2025 - 11/30/2025
10/01/2025 - 10/31/2025
09/01/2025 - 09/30/2025
08/01/2025 - 08/31/2025
07/01/2025 - 07/31/2025
06/01/2025 - 06/30/2025
05/01/2025 - 05/31/2025
04/01/2025 - 04/30/2025
03/01/2025 - 03/31/2025
02/01/2025 - 02/28/2025
01/01/2025 - 01/31/2025
12/01/2024 - 12/31/2024
11/01/2024 - 11/30/2024
10/01/2024 - 10/31/2024
09/01/2024 - 09/30/2024
08/01/2024 - 08/31/2024
07/01/2024 - 07/31/2024
06/01/2024 - 06/30/2024
05/01/2024 - 05/31/2024
04/01/2024 - 04/30/2024
03/01/2024 - 03/31/2024
02/01/2024 - 02/29/2024
01/01/2024 - 01/31/2024
12/01/2023 - 12/31/2023
11/01/2023 - 11/30/2023
10/01/2023 - 10/31/2023
09/01/2023 - 09/30/2023
08/01/2023 - 08/31/2023
07/01/2023 - 07/31/2023
06/01/2023 - 06/30/2023
05/01/2023 - 05/31/2023
04/01/2023 - 04/30/2023
03/01/2023 - 03/31/2023
02/01/2023 - 02/28/2023
01/01/2023 - 01/31/2023
12/01/2022 - 12/31/2022
11/01/2022 - 11/30/2022
10/01/2022 - 10/31/2022
09/01/2022 - 09/30/2022
08/01/2022 - 08/31/2022
07/01/2022 - 07/31/2022
06/01/2022 - 06/30/2022
05/01/2022 - 05/31/2022
04/01/2022 - 04/30/2022
03/01/2022 - 03/31/2022
02/01/2022 - 02/28/2022
01/01/2022 - 01/31/2022
12/01/2021 - 12/31/2021
11/01/2021 - 11/30/2021
10/01/2021 - 10/31/2021
09/01/2021 - 09/30/2021
08/01/2021 - 08/31/2021
07/01/2021 - 07/31/2021
06/01/2021 - 06/30/2021
05/01/2021 - 05/31/2021
04/01/2021 - 04/30/2021
03/01/2021 - 03/31/2021
02/01/2021 - 02/28/2021
01/01/2021 - 01/31/2021
12/01/2020 - 12/31/2020
11/01/2020 - 11/30/2020
10/01/2020 - 10/31/2020
09/01/2020 - 09/30/2020
08/01/2020 - 08/31/2020
07/01/2020 - 07/31/2020
06/01/2020 - 06/30/2020
05/01/2020 - 05/31/2020
04/01/2020 - 04/30/2020
03/01/2020 - 03/31/2020
02/01/2020 - 02/29/2020
01/01/2020 - 01/31/2020
12/01/2019 - 12/31/2019
11/01/2019 - 11/30/2019
10/01/2019 - 10/31/2019
09/01/2019 - 09/30/2019
08/01/2019 - 08/31/2019
07/01/2019 - 07/31/2019
06/01/2019 - 06/30/2019
05/01/2019 - 05/31/2019
04/01/2019 - 04/30/2019
03/01/2019 - 03/31/2019
02/01/2019 - 02/28/2019
01/01/2019 - 01/31/2019
12/01/2018 - 12/31/2018
11/01/2018 - 11/30/2018
10/01/2018 - 10/31/2018
09/01/2018 - 09/30/2018
08/01/2018 - 08/31/2018
07/01/2018 - 07/31/2018
06/01/2018 - 06/30/2018
05/01/2018 - 05/31/2018
04/01/2018 - 04/30/2018
03/01/2018 - 03/31/2018
02/01/2018 - 02/28/2018
01/01/2018 - 01/31/2018
11/01/2017 - 11/30/2017
10/01/2017 - 10/31/2017
09/01/2017 - 09/30/2017
08/01/2017 - 08/31/2017
07/01/2017 - 07/31/2017
06/01/2017 - 06/30/2017
05/01/2017 - 05/31/2017
04/01/2017 - 04/30/2017
03/01/2017 - 03/31/2017
02/01/2017 - 02/28/2017
01/01/2017 - 01/31/2017
12/01/2016 - 12/31/2016
11/01/2016 - 11/30/2016
10/01/2016 - 10/31/2016
09/01/2016 - 09/30/2016
08/01/2016 - 08/31/2016
07/01/2016 - 07/31/2016
06/01/2016 - 06/30/2016
05/01/2016 - 05/31/2016
04/01/2016 - 04/30/2016
03/01/2016 - 03/31/2016
02/01/2016 - 02/29/2016
01/01/2016 - 01/31/2016
12/01/2015 - 12/31/2015
11/01/2015 - 11/30/2015
10/01/2015 - 10/31/2015
09/01/2015 - 09/30/2015
08/01/2015 - 08/31/2015
07/01/2015 - 07/31/2015
06/01/2015 - 06/30/2015
05/01/2015 - 05/31/2015
04/01/2015 - 04/30/2015
03/01/2015 - 03/31/2015
02/01/2015 - 02/28/2015
01/01/2015 - 01/31/2015
12/01/2014 - 12/31/2014
11/01/2014 - 11/30/2014
10/01/2014 - 10/31/2014
发表评论
作者:
用户名: 密码: 您还不是博客/论坛用户?现在就注册!
     
评论:
有人说.千万不要接种美国FDA批准莫德纳75%不良反应の流感疫苗
   

image.png


Pleae whatever you do... DO NOT TAKE THE NEW FDA APPROVED 

mFLUSIVA mRNA FLU SHOT

Moderna’s first-ever mRNA flu vaccine was FDA-approved and 

rushed to market —  loaded with red flags that echo COVID-era 

patterns.

• 75.7% of mFLUSIVA recipients reported adverse reactions within 

7 days... fever, extreme fatigue, severe headache and pain.

• Severe systemic reactions were 5–6X higher with illness occurring 

in 1 out of every 20 participants.

• The “placebo” was not saline — it was another flu vaccine Fluarix: 

No true inert placebo means the safety contrast is gone, and 

absolute risk versus nothing is unknown.

• Safety follow-up was only about 6 months: Long-term effects, rare 

events, and multi-year outcomes remain completely untracked in 

the published data.

• There were 102 deaths in the mRNA group: The FDA labeled them 

unrelated, yet no autopsies were performed — leaving complete 

uncertainty.

• Same technology. Same pattern: Built on the identical mRNA 

platform as the COVID shots that produced high injuries, illnesses 

and deaths.


无论如何,请千万不要接种这款 2026年8月5日获得美国食品药品

监督管理总局(FDA)批准的 mRNA 流感疫苗——mFLUSIVA。


Moderna 公司推出的这款 mRNA 流感疫苗(首款此类疫苗)在获批

后被迅速推向市场,其背后存在诸多令人警惕的信号,与新冠疫情

期间的情况如出一辙。


• 75.7 % 的 mFLUSIVA 接种者在 7 天内出现了不良反应,包括发热、

极度疲劳、剧烈头痛及疼痛。


• 严重全身性反应的发生率高出 5 到 6 倍,平均每 20 名受试者中就

有 1 人出现此类严重反应。


• 试验中所谓的“安慰剂”并非生理盐水,而是另一种流感疫苗 

Fluarix。由于缺乏真正惰性的安慰剂,安全性对比便无从谈起,

也无法评估其相对于“不接种任何疫苗”时的绝对风险。


• 安全性随访期仅约 6 个月;已发布的数据完全未涵盖长期影响、

罕见不良事件以及多年后的健康后果。


• 在 mRNA 疫苗组中,共有 102 人死亡。尽管 FDA 认定这些死亡与

疫苗无关,但由于未进行尸检,实际情况仍充满未知。


• 技术相同,模式如出一辙:该疫苗所采用的 mRNA 平台,与此前

曾导致大量伤害、疾病和死亡的新冠疫苗所用的平台完全一致。


image.png


Image


image.png

https://journalofindependentmedicine.org/articles/v02n05a07/


image.png

image.png

image.png


我曾劝过我在单位的朋友你可别去打那些针!

结果,他特意跑去找医生,一口气打了一堆疫苗,

回来后,为此沾沾自喜!


他给我发了条信息,说:

“   瞧,我刚刚打了新冠、流感、麻疹、肺炎疫苗。 ”


https://x.com/Bruce98048832/status/2117853977773801612


 
关于本站 | 广告服务 | 联系我们 | 招聘信息 | 网站导航 | 隐私保护
Copyright (C) 1998-2026. Creaders.NET. All Rights Reserved.